- Home
- ATRC vs KFRC Comparison
ATRC vs KFRC Comparison
Compare ATRC & KFRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATRC
- KFRC
- Stock Information
- Founded
- ATRC 2000
- KFRC 1962
- Country
- ATRC United States
- KFRC United States
- Employees
- ATRC N/A
- KFRC N/A
- Industry
- ATRC Medical/Dental Instruments
- KFRC Professional Services
- Sector
- ATRC Health Care
- KFRC Consumer Discretionary
- Exchange
- ATRC Nasdaq
- KFRC Nasdaq
- Market Cap
- ATRC 1.1B
- KFRC N/A
- IPO Year
- ATRC 2005
- KFRC 1995
- Fundamental
- Price
- ATRC $39.84
- KFRC $54.84
- Analyst Decision
- ATRC Strong Buy
- KFRC Buy
- Analyst Count
- ATRC 9
- KFRC 3
- Target Price
- ATRC $43.00
- KFRC $66.67
- AVG Volume (30 Days)
- ATRC 618.4K
- KFRC 95.7K
- Earning Date
- ATRC 02-12-2025
- KFRC 02-03-2025
- Dividend Yield
- ATRC N/A
- KFRC 2.78%
- EPS Growth
- ATRC N/A
- KFRC N/A
- EPS
- ATRC N/A
- KFRC 2.68
- Revenue
- ATRC $447,573,000.00
- KFRC $1,405,308,000.00
- Revenue This Year
- ATRC $18.02
- KFRC N/A
- Revenue Next Year
- ATRC $12.93
- KFRC $0.84
- P/E Ratio
- ATRC N/A
- KFRC $20.41
- Revenue Growth
- ATRC 17.56
- KFRC N/A
- 52 Week Low
- ATRC $18.94
- KFRC $52.96
- 52 Week High
- ATRC $43.11
- KFRC $74.79
- Technical
- Relative Strength Index (RSI)
- ATRC 61.66
- KFRC 35.17
- Support Level
- ATRC $39.71
- KFRC $55.15
- Resistance Level
- ATRC $43.11
- KFRC $56.64
- Average True Range (ATR)
- ATRC 1.86
- KFRC 1.19
- MACD
- ATRC 0.15
- KFRC -0.04
- Stochastic Oscillator
- ATRC 63.10
- KFRC 3.16
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.